The Norwegian Lundehund puppies are an extraordinary breed prized for their agility and rich history. Originating from Norway, these small spitz-type dogs are notable not only for their unique physical traits but also for some inherited health challenges, particularly Lundehund syndrome. This detailed guide breaks down what the syndrome entails and how to navigate DNA testing for your Lundehund in the USA as of 2025.
Lundehund syndrome, also known as intestinal lymphangiectasia, is a genetic gastrointestinal condition present in Norwegian Lundehunds. It encompasses multiple problems such as protein-losing enteropathy, persistent gastroenteropathy, and bacterial overgrowth, all contributing to inefficient nutrient absorption, vomiting, diarrhea, and weight loss.
This syndrome is caused by an autosomal recessive mutation in the LEPREL1 gene, meaning a dog must inherit two faulty gene copies, one from each parent, to be affected. Symptoms typically surface between 6 months and up to 10 years of age. Unfortunately, chronic inflammation linked to this syndrome can lead to critical complications like lymphoma, intestinal cancers, and potential organ perforation.
Leading veterinary experts in the US emphasize genetic testing combined with responsible breeding practices to help control LS incidence, supplemented by careful clinical care for affected dogs.
Lundehund syndrome is inherited through an autosomal recessive pattern, so the genetic status of both parents determines each puppy's likelihood of being affected. There are three possible genetic outcomes for a dog:
The breeding combinations and their outcomes include:
Reach out to your local veterinary clinic to discuss DNA testing options for Lundehund syndrome. Be specific to ensure your veterinarian prepares for the appropriate test.
The veterinarian will collect a DNA sample, usually via a cheek swab. Occasionally, blood samples might be required. This is a quick, non-invasive, and painless process for your dog.
Your vet will send the sample to a US-based or internationally accredited laboratory approved for Lundehund syndrome testing. These labs analyze the mutation in the LEPREL1 gene associated with the condition.
The laboratory assesses whether your Norwegian Lundehund is clear, a carrier, or affected. Results generally return within a few weeks.
You will receive a detailed report from your veterinario explaining your dog's genetic status. Use this vital information to make informed breeding decisions or to closely monitor your dog’s health.
If you’re a breeder, avoid pairing two carriers or affected dogs to prevent at-risk puppies. For affected dogs, collaborate with your vet to manage symptoms through specialized diets and supportive care as there is currently no cure. Early diagnosis is key to improving long-term outcomes.
Due to their historically narrow genetic pool, managing Lundehund syndrome requires careful breeding strategies within the United States. While less common in the US compared to Scandinavia, some breeders are exploring outcrossing programs with related breeds to boost genetic diversity responsibly, always maintaining the distinctive qualities of the Lundehund.
Prospective owners and current ones should always choose reputable breeders who perform comprehensive health screening and openly share genetic test results.
Lundehund syndrome is a challenging inherited disorder for the Norwegian Lundehund breed, but its impact can be mitigated through DNA testing and conscientious breeding plans. Utilizing the testing process through your veterinarian and implementing recommended breeding protocols will support lowering the syndrome’s occurrence and safeguarding the health of future generations.